The tumor-suppressive function of CST6 has also been reported in lung cancer (Zhong et al., 2007), melanoma (Briggs et al., 2010), and renal cell carcinoma (Morris et al., 2010), which agreed with the loss expression of CST6 in these cancer types. This evidence concerns the gene CST6 and hereditary clear cell renal cell carcinoma.